leadf
logo-loader
viewSienna Cancer Diagnostics Ltd

Sienna Cancer Diagnostics to launch its in-vitro test in Denmark and Sweden

New distribution agreement to accelerate the global roll out of Sienna’s hTERT IVD test.

Cancer header on a newspaper
Sienna's test help urologists detect bladder cancer

Sienna Cancer Diagnostics Ltd (ASX:SDX) has appointed Axlab A/S as the exclusive distribution partner for its in-vitro diagnostic (IVD) tests in Denmark and Sweden.

The Australia based Sienna’s hTERT test help urologists to detect bladder cancer earlier, and thereby improve patient welfare and lower overall costs in the healthcare system.

This new distribution agreement will broaden and accelerate the global roll out of Sienna’s hTERT IVD test.

Additionally, the agreement provides Axlab with the right to sell Sienna’s product to pathology laboratories.

Axlab is a Denmark based experienced supplier of instruments, reagents and consumables for histology and cytology.

Sienna plans to penetrate its products into the Nordic market using Axlab’s existing facilities and significant knowledge in cytology.

Sienna's primary platform is the detection of the biomarker telomerase, which is found in nearly all epithelial cancers, and was the subject of a Nobel Prize in 2009.

The regulation of telomerase activity in human cells plays a significant role in the development of cancer.

Importantly, clinical pathology laboratories in the region may now purchase Sienna’s IVD product to detect the presence of hTERT, a component of telomerase.

Quick facts: Sienna Cancer Diagnostics Ltd

Price: - -

ASX:SDX
Market: ASX
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Davide Bosio previews hotly anticipated IPOs for Miramar Resources and Zebit

Davide Bosio from Shaw and Partners says it's been a terrific start to the listing process for Miramar Resources, a junior West Australia exploration company. ''We opened up the offer and closed literally on the same day raising $8mln''. Bosio adds that Zebit is still on track to list on the ASX...

2 days, 9 hours ago

2 min read